RecruitingNot ApplicableNCT07214948

Open, Randomized Feasibility Trial on the Safety and Performance of the INGA Catheter for Labor Induction

An Open, Parallel-group, Randomized, Early Feasibility Trial to Evaluate the Initial Safety and Performance of the INGA Catheter in Labor Induction


Sponsor

Aalto University

Enrollment

40 participants

Start Date

Jul 3, 2026

Study Type

INTERVENTIONAL

Conditions

Summary

This study investigates the safety and usability of the new INGA catheter for labor induction. Labor induction is common, with about one in three births being induced. In this study, the INGA catheter will be compared to a currently used method. The INGA catheter is a single-balloon device that works similarly to a Foley catheter but is made from different materials. Feedback will be collected from both healthcare professionals and participating women.


Eligibility

Sex: FEMALEMin Age: 18 YearsMax Age: 56 Years

Inclusion Criteria7

  • Pregnant women aged ≥18 and ≤56 years
  • An unripe cervix, ≤6 points according to the Bishop score assessment (0-10-point scale)
  • Planned induction of labor by balloon catheter method
  • Gestational age at the time of the study ≥ 37 weeks (gestational age confirmed by ultrasound before the 21st week of pregnancy)
  • Singleton pregnancy
  • Cephalic presentation
  • The subject understands the study information and signs the informed consent

Exclusion Criteria20

  • Preterm induction of labor (<37 weeks of gestation)
  • Abnormal Cardiotocography (CTG) at inclusion
  • Spontaneous rupture of membranes at inclusion
  • Clinically significant vaginal bleeding with a need of hospitalization in the third trimester
  • Clinical active vaginal or uterine infection
  • Maternal Human Immunodeficiency Virus (HIV), hepatitis C, or hepatitis B
  • Uterine scar (including previous cesarean section)
  • Condition requiring immediate delivery of the fetus or mother
  • Presence of eclampsia
  • Severe Preeclampsia \[Blood pressure (BP)≥ 160/110 and any of the following: thrombocytopenia with platelet count <100 × 10e9/L, HELLP- syndrome ( Hemolysis, Elevated Liver enzymes and Low Platelets), progressive renal insufficiency, pulmonary edema \]
  • Severe fetal growth restriction (Fetal Growth Restriction (FGR) fetal growth <-2 SD/<10th percentile)
  • Estimated fetal weight ≥ 2 Standard Deviation /≥ 95th percentile
  • Reduced amniotic fluid volume (deepest vertical pocket <30 mill meter)
  • Breech or transverse fetal position
  • Multiple pregnancy
  • Vasa previa or placenta previa
  • Umbilical cord prolapses
  • Bishop score ≥6 on cervical assessment prior to labor induction
  • Receiving epidural anesthesia prior to catheter insertion
  • Refusal to participate in the study and/or insufficient language skills to understand the study information and/or consent form

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEINGA Catheter

Insertion of the INGA balloon catheter (medical device) through the cervical canal into the uterus is performed for labor induction. During a vaginal examination, the Investigator inserts the catheter so that the balloon tip lies between the amniotic membranes and the internal cervical os. The balloon is filled with 50-75 ml of sterile saline (NaCl) and secured to the upper thigh to maintain gentle traction. The catheter remains in place for up to 24 hours or until spontaneous expulsion. If not expelled, it is removed after 24 hours. After expulsion or removal, cervical status and Bishop score are assessed. If Bishop ≥ 6, amniotomy and/or oxytocin induction are initiated within one hour. If Bishop \< 6, further management follows

DEVICECurrently used single balloon catheter

Insertion of a balloon catheter through the cervical canal into the uterus for induction of labor.


Locations(2)

University of Minnesota Medical School

Minneapolis, Minnesota, United States

University of Mississippi Medical Center

Jackson, Mississippi, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07214948


Related Trials